Home > Result Summaries: Compounds > ropinirole > Result Summary for 101468/180

Result Summary for 101468/180

Result Summary

Protocol ID:	101468/180
Clinical Study ID:	SK&F-101468/180
Official Title:	A clinical evaluation of ropinirole hydrochloride (SK&F101468) used jointly with L dopa for Parkinson's Disease - a double-blind group comparative trial with placebo as comparison
Phase:	Phase 3
Study Indications or Diseases:	Parkinson Disease
Generic Name:	ropinirole
Trade/Product Name:	requip
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Mizuno Y. Abe T. Hasegawa K. Kuno S. Kondo T. Yamamoto M. Nakashima M. Kanazawa I. STRONG Study Group. Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Movement Disorders. 22(13):1860-5, 2007 Oct 15.